Chemical synthesis produced a luminescent compound with rare earth elements, suggesting potential for medical applications.
As a result of the chemical synthesis, a heterogeneous compound with luminescent properties was obtained, containing rare-earth metal ions (Er3+, Nd3+), Mo6+, and Zr4+. The reaction was carried out using solutions of Na2MoO4, ZrOCl2, NdCl3, and ErCl3 at a temperature of 22 °C. After 30─35 days, the system reached equilibrium, and an insoluble greyish-blue precipitate was formed. ICP-AES analysis confirmed the presence of all the initial components and showed the heterogeneity of the material; the molar ratio nNa : nMo : nZr : nEr : nNd = 0.05 : 0.22 : 0.086 : 0.082 : 0.05 was confirmed in the system. X-ray microanalysis revealed a complex multiphase structure characterized by significant chemical diversity and the presence of nanoparticles. Partial emission of Nd3+ at a wavelength of around 885 nm (4F3/2 → 4I9/2 transition) was found by luminescence investigations; this can be utilised in medical near-infrared laser systems. Spectrometer constraints prevented the detection of Er3+ emission. The material's molybdenum-based structure and the presence of Zr4+ ions are responsible for the visible glow. Although more research is necessary to completely comprehend the Er3+ emission, the acquired findings suggest the possibility of developing complex heterogeneous luminous compounds containing rare earth ions for optical and medicinal applications.
No takes yet. Share an insight, caveat, or question.
Nersisyan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: